Team:HKUST/Group1

From 2009.igem.org

(Difference between revisions)
 
(24 intermediate revisions not shown)
Line 18: Line 18:
<li><a href="https://2009.igem.org/Team:HKUST">Home</a></li>
<li><a href="https://2009.igem.org/Team:HKUST">Home</a></li>
<li><a href="https://2009.igem.org/Team:HKUST/Team">Our Team</a></li>
<li><a href="https://2009.igem.org/Team:HKUST/Team">Our Team</a></li>
-
<li><a href="https://2009.igem.org/Team:HKUST/Project">Project description</a></li>
+
<li><a href="https://2009.igem.org/Team:HKUST/Project">Project Description</a></li>
-
<li><a href="https://2009.igem.org/Team:HKUST/Background">Background</a></li>
+
 
-
<li><a href="https://2009.igem.org/Team:HKUST/Experiment">Experimental design</a></li>
+
<b>
 +
<span style="color:green">
 +
<li>Main Parts</li>
 +
</span>
 +
</b>
 +
<li><a href="https://2009.igem.org/Team:HKUST/OdorantSensing">Odorant Sensing</a></li>
 +
<li><a href="https://2009.igem.org/Team:HKUST/AttractantProduction">Attractant Production</a></li>
 +
<li><a href="https://2009.igem.org/Team:HKUST/ToxinProduction">Toxin Production</a></li>
 +
 
 +
<b>
 +
<span style="color:green">
 +
<li>Resources</li>
 +
</span>
 +
</b>
 +
 
<li><a href="https://2009.igem.org/Team:HKUST/Lab Notebook">Lab Notebook</a></li>
<li><a href="https://2009.igem.org/Team:HKUST/Lab Notebook">Lab Notebook</a></li>
-
<li><a href="https://2009.igem.org/Team:HKUST/Result">Experimental result</a></li>
 
<li><a href="https://2009.igem.org/Team:HKUST/Parts">Parts Submitted </a></li>
<li><a href="https://2009.igem.org/Team:HKUST/Parts">Parts Submitted </a></li>
-
<li><a href="https://2009.igem.org/Team:HKUST/Protocols">Protocol list</a></li>
+
<li><a href="https://2009.igem.org/Team:HKUST/Protocols">Protocol List</a></li>
-
<li><a href="https://2009.igem.org/Team:HKUST/Resourses">Other resources</a></li>
+
<li><a href="https://2009.igem.org/Team:HKUST/Resourses">Other Resources</a></li>
-
<li><a href="https://2009.igem.org/Team:HKUST/Future">Future plan</a></li>
+
</ul>
</ul>
</div>
</div>
Line 32: Line 44:
<ul>
<ul>
<li><a href="https://2009.igem.org/Team:Gallery">Gallery</a></li>
<li><a href="https://2009.igem.org/Team:Gallery">Gallery</a></li>
-
<li><a href="https://2009.igem.org/Team:Consolidation">Consolidation</a></li>
+
<li><a href="https://2009.igem.org/Team:Biosafety">Biosafety</a></li>
<li><a href="https://2009.igem.org/Team:Acknowledgement">Acknowledgement</a></li>
<li><a href="https://2009.igem.org/Team:Acknowledgement">Acknowledgement</a></li>
</ul>
</ul>
Line 38: Line 50:
</div>
</div>
<div id="rightxx">
<div id="rightxx">
 +
<div class="contentodS_d"> <h3>a</h3>
 +
</div>
<div class="contentxx">
<div class="contentxx">
-
<h3>Welcome</h3>
+
-
+
<p>Construction of Receptor Expression Cassette</p>
-
<p>Chimeric Receptor Construction</p>
+
  To functionally express <em>C. elegans</em> ODR-10 receptor, we have designed an expression cassette. Based on the fact that rat I7 (RI7) receptor has been successfully expressed in the yeast system with effective coupling to the Gαolf subunit, we have designed a chimeric receptor with the RI7 N (amino acids 1-61 of RI7) and C termini (animo acids 295-327 of RI7) fused to the ODR-10 transmambrane domains two to seven (TM2 – 7, amino acids 48-305 of ODR-10, starting from the fourth amino acid of Odr10 TM2)  [7,8] (Figure 3). At the N terminus side, the two fragments are fused at the junctions PMYFF (RI7) and YLMAFF (ODR-10), because these two sequences are conserved in both receptor junction sites (Figure 4).<br><br>
-
<p>The chimeric receptor expression cassette contains the N- and C- terminals of the rat OR RI7, flanking the TM2-TM7 ligand-binding domain of the c. elegans OR odr-10. The receptor sequence is first derived through fusion PCR, and then cloned into the yeast expression vector pESC-His for further localization and functional assay.</p>
+
The fused chimeric receptor is then cloned into the multiple cloning site of pESC-HIS expression vector under the GAL1 promoter. It is also tagged with FLAG or GFP at the C terminus for protein expression detection or localization test. Given that we have retained the N and C termini of RI7, localization and subsequent coupling should not be perturbed.</p><br><br>
-
<p>I. Primer DesignI. </p>
+
<img src="http://igem2009hkust.fileave.com/wiki/Group1/figure03.jpg " width=584; height=372 /></a><br>
-
<p>We have designed several sets of primers for parts and BioBrick construction and DNA sequencing. The primer sequences are listed in Table 1. Primer statistics are calculated using NetPrimer.</p>
+
-
<p>For the chimeric receptor, primers are designed with 10 bp overlapping overhangs at the fusion junctions so that the fragments can anneal in fusion PCR. Two different reverse primers have been designed for the RI7 scaffold primers, one with stop codon incorporated into the sequence, and the other without. These two different alternatives can be chosen for construction of receptors with or without localization tags. In addition, nucleotide sequence in the primers has been modified in a few places to adjust for codon bias among c.elegans, rat and budding yeast. </p>
+
-
<p>The following diagram illustrates the schematic of the main primer design for the chimeric receptor. </p>
+
-
<a href="http://www.freewebsitetemplates.com"><img src="http://igem2009hkust.fileave.com/wiki/Group1/Gp1 Fusion design.jpg " width="550" height="200"  /></a>
+
<img src="http://igem2009hkust.fileave.com/wiki/Group1/figure04.jpg " width=584; height=308 /></a><br>
-
<p>Table 1  Primer sequences designed for the constructions</p>
+
</p>
-
<a href="http://www.freewebsitetemplates.com"><img src="http://igem2009hkust.fileave.com/wiki/Group1/Group 1 TablePrimer.JPG  " width="550" height="700"  /></a>
+
-
<p>*Note: </p>
+
<br><br>
-
<p>1. Restriction sites are highlighted in blue.</p>
+
<p>Test of Chimeric Protein Localization</p>
-
<p>2. Overhangs for fusion junctions are highlighted in red.</p>
+
  To test the localization of chimeric receptors, we have made the construct pESC-Fusion-GFP, which is the chimeric protein with the GFP tag at the C terminus in the expression vector pESC-HIS, as well as the negative control pESC-GFP, which has only GFP cloned into the same site in the expression vector pESC-HIS (Figure 5). We choose to tag GFP at the C terminus because the N terminus of the fusion protein is important for membrane localization while the C terminus is important for downstream coupling. Since we want to ensure proper localization of the protein, it is better to fuse GFP at the C terminus.     </p><br><br>
-
<p>3. Stop codons </p>
+
-
<p>#Note:</p>
+
<img src="http://igem2009hkust.fileave.com/wiki/Group1/figure05.jpg  " width=612; height=358 /></a>
-
<p>For the fusion primers P3-P6, whole sequence Tm is indicated in black, while Tm for the main annealing part (without calculating overhang) is indicated in green.</p>
+
-
<p>II. PCR</p>
+
<br><br>
-
<p>For optimized PCR efficiency and accuracy, Vent polymerase is chosen for amplification PCR reactions; KOD polymerase is used for fusion PCR. Gradient PCR is carried out for each step to optimize the reaction.
+
-
The DNA fragments coding for the RI7 localization scaffold and the odr-10 ligand-binding pocket are first amplified separately from respective cDNA template (pHeI4 for RI7 and pPD9S.77 for odr-10) via PCR. These fragments are then fused together via fusion PCR.</p>
+
-
<p>In fusion PCR, reaction conditions and reactant concentrations must be carefully controlled to obtain satisfactory yields. DNA fragment fusion must be carried out in a stepwise process, by fusing RI7-N and odr-10 first (using P1 and P5), followed by annealing this fused sequence to the RI7-C fragment (using P1 and P2). PCR cleanup is essential in the procedures, preferably by gel purification, since residual primers may affect the reaction in the next step, leading to amplification of the original template instead of desired fusion reaction. </p>
+
-
<p>In the reaction, the two fragment templates are allowed to go through 1 to 2 PCR cycles without primers in order to create a fused template for amplification. The amplification primers are then added to the reaction mixture to allow for amplification of the whole fused sequence.
+
</p>
</p>
-
<p>III. Cloning</p>
+
  After transformation and selection, we would induce the transformants with galactose at the exponential stage of yeast growth. After some time, we would harvest cells for the fluorescence microscopy test. We would expect to see the cells transformed with pESC-Fusion-GFP to have strong green fluorescence surrounding the cell, forming a green halo; whilst the negative control does not. In that case, we could say that the fusion protein is able to localize in the yeast membrane. </p><br><br>
-
<p>After the chimeric receptor sequence is successfully derived through fusion PCR, standard cloning procedures are followed to construct a receptor expression cassette. </p>
+
-
<p>The pESC yeast epitope tagging vector pESC-HIS is used in the expression cassette construction. The chimeric receptor insert is cloned into MCS1 of the vector (under GAL10 promoter; with FLAG epitope tag) between the restriction sites EcoRI and NotI. The RI7 control construct can also be generated in the same way.</p>
+
-
<p>A GFP-tagged receptor can be generated by cloning the GFP tag into a constructed receptor expression vector, between the MCS1 sites of SpeI and SacI, replacing the FLAG epitope.</p>
+
-
<a href="http://www.freewebsitetemplates.com"><img src="http://igem2009hkust.fileave.com/wiki/Group1/Gp1 pESC-HIS.jpg " width="550" height="200"  /></a>
+
-
<a href="http://www.freewebsitetemplates.com"><img src="http://igem2009hkust.fileave.com/wiki/Group1/Gp1 pESC-HIS flag.jpg " width="550" height="200"  /></a>
+
<p>Test of Chimeric Protein Function</p>
 +
  To test the functional odorant sensing and Gα subunit coupling, we have made several constructs: <br><br>
 +
<img src="http://igem2009hkust.fileave.com/wiki/Group1/figure06.jpg" width=573; height=575 />
 +
</p><br><br>
-
+
There are two parts in the fuctional coupling test:</p>
-
+
<br><br>
 +
<b>Part 1</b><br>
 +
First we test whether our chimeric protein could couple to Gpa1. <br><br>
 +
The yeasts would be transformed with construct (1)+(4) or (2)+(4) or (5)+(4), respectively. After induction with galactose to express the receptors, we would add the ligands diacetyl (for ODR-10) and hexanal (for RI7). After some time of ligand binding, we would expect to see that the functional receptors could couple to Gpa1 and then trigger downstream FUS1-promoter-driven expression of GFP, together with cell cycle arrest at G1 phase (figure 6). The expression of GFP could be viewed by fluorescence microscopy; the cell cycle arrest could be confirmed by fluorescence-activated cell sorting (FACS). We expect to see the fusion receptor and RI7 respond to diacetyl and hexanal respectively, and have GFP expression and cell cycle arrest. In that case we could say that fusion receptor could functionally couple to Gpa1 and initiate downstream signalling. <br><br>
 +
 
 +
<img src="http://igem2009hkust.fileave.com/wiki/Group1/figure07.jpg" width=600; height=515 />
 +
 
 +
<br><br>
 +
<b>Part 2</b><br>
 +
  Second, we test whether our chimeric receptor could couple to Gαolf for optimized signal transduction, as well as construct a testable yeast system for odorant sensing.  <br><br>
 +
 
 +
Before testing, the yeast strain needs to be manipulated: we need to knock out the FAR1 gene, which encodes a protein that controls cell cycle arrest upon activation of the MAPK pathway. After deletion of the FAR1 gene, the yeast will still be viable after ligand binding. We also need to knock out the endogenous GPA1 gene, so that we could replace it with Gαolf. Due to the second messenger activity of the free G protein βγ subunit, haploid <em>S. cerevisiae</em> strains with a null mutation of GPA1 undergo constitutive pheromone response of G1 arrest, resulting in non-viability[9]. So, we need to first knock out the cell cycle regulatory gene FAR1 and afterwards, GPA1. To knock out these two genes, we have adopted the PCR-based tagging of yeast genes method, introduced by Janke C., <em>et al</em>, 2004[10]. <br><br>
 +
To test for successful deletion, we will use both PCR confirmation (Figure 7) and phenotype observation after adding α-factor (no mating phenotype). </p><br><br>
 +
 
 +
<img src="http://igem2009hkust.fileave.com/wiki/Group1/figure08.jpg" width=585; height=465 />
 +
<br><br>
 +
  Next, we need to transform Gαolf into the double knock-out strain to check for positive transformants. It has been reported that Gαolf can not only complement for a GPA1 deficiency but also functionally couple to the pheromone receptor STE211. Thus we have developed assays to select for functional Gαolf transformants (Figure 8). </p><br><br>
 +
 +
<img src="http://igem2009hkust.fileave.com/wiki/Group1/figure09.jpg" width=607; height=413 />
 +
</p>
 +
<br><br>
 +
After confirmation of functional Gαolf,  we would use this strain to test its ligand binding using the same method shown in Figure 6. However, this time we would expect to see no cell cycle arrest in any case since FAR1 has been deleted. We expect the ligand binding assay this time to give an optimized coupling and signal transduction. </p><br><br>
 +
 
 +
<p>Further Characterization of the Chimeric Protein Function</p>
 +
  To further characterize how this chimeric receptor functions, we can do the following assays: <br><br>
 +
  First, we can test how the recptor responds to different ligand concentrations. According to literature, <em>C. elegans</em> ODR-10 gives strongest response to 100μM diacetyl[11], and we can then compare the intensity of GFP production under a series of diacetyl concentrations. <br><br>
 +
  Second, we can test the ligand specificity of the chimeric protein. According to literature, ODR-10 responds to the volatile molecule diacetyl, as well as the non-volatile molecules pyruvic acid and citric acid[13]. We can also test whether it can respond to other volatile molecules by setting up similar assays as shown in Figure 6. <br>
 +
 
 +
<br><br>
 +
<br>
 +
<li><a href="https://2009.igem.org/Team:HKUST/Back1">Background</a></li>
 +
<li><a href="https://2009.igem.org/Team:HKUST/Group1">Experimental Design</a></li>
 +
<li><a href="https://2009.igem.org/Team:HKUST/Part1">Parts Design</a></li>
 +
<li><a href="https://2009.igem.org/Team:HKUST/Result1">Experimental Results</a></li>
 +
<li><a href="https://2009.igem.org/Team:HKUST/Future1">Future Work</a></li>
 +
<li><a href="https://2009.igem.org/Team:HKUST/Ref1">References</a></li>
 +
                </div>
                </div>
Line 92: Line 131:
<span> iGEM 2009 <br /> </span>  
<span> iGEM 2009 <br /> </span>  
</div>
</div>
-
<div id="payment"><img src="http://igem2009hkust.fileave.com/wiki/template/12092009/images/HKUSTLogo.jpg" alt="paypal" /></div>
+
<div id="payment"><img src="http://igem2009hkust.fileave.com/wiki/template/12092009/images/HKUSTLogo.jpg" alt="HKUST" /></div>
</div>
</div>
<div id="footerend"></div>
<div id="footerend"></div>

Latest revision as of 20:36, 21 October 2009

Salt and Soap template

a

Construction of Receptor Expression Cassette

To functionally express C. elegans ODR-10 receptor, we have designed an expression cassette. Based on the fact that rat I7 (RI7) receptor has been successfully expressed in the yeast system with effective coupling to the Gαolf subunit, we have designed a chimeric receptor with the RI7 N (amino acids 1-61 of RI7) and C termini (animo acids 295-327 of RI7) fused to the ODR-10 transmambrane domains two to seven (TM2 – 7, amino acids 48-305 of ODR-10, starting from the fourth amino acid of Odr10 TM2) [7,8] (Figure 3). At the N terminus side, the two fragments are fused at the junctions PMYFF (RI7) and YLMAFF (ODR-10), because these two sequences are conserved in both receptor junction sites (Figure 4).

The fused chimeric receptor is then cloned into the multiple cloning site of pESC-HIS expression vector under the GAL1 promoter. It is also tagged with FLAG or GFP at the C terminus for protein expression detection or localization test. Given that we have retained the N and C termini of RI7, localization and subsequent coupling should not be perturbed.







Test of Chimeric Protein Localization

To test the localization of chimeric receptors, we have made the construct pESC-Fusion-GFP, which is the chimeric protein with the GFP tag at the C terminus in the expression vector pESC-HIS, as well as the negative control pESC-GFP, which has only GFP cloned into the same site in the expression vector pESC-HIS (Figure 5). We choose to tag GFP at the C terminus because the N terminus of the fusion protein is important for membrane localization while the C terminus is important for downstream coupling. Since we want to ensure proper localization of the protein, it is better to fuse GFP at the C terminus.





After transformation and selection, we would induce the transformants with galactose at the exponential stage of yeast growth. After some time, we would harvest cells for the fluorescence microscopy test. We would expect to see the cells transformed with pESC-Fusion-GFP to have strong green fluorescence surrounding the cell, forming a green halo; whilst the negative control does not. In that case, we could say that the fusion protein is able to localize in the yeast membrane.



Test of Chimeric Protein Function

To test the functional odorant sensing and Gα subunit coupling, we have made several constructs:



There are two parts in the fuctional coupling test:



Part 1
First we test whether our chimeric protein could couple to Gpa1.

The yeasts would be transformed with construct (1)+(4) or (2)+(4) or (5)+(4), respectively. After induction with galactose to express the receptors, we would add the ligands diacetyl (for ODR-10) and hexanal (for RI7). After some time of ligand binding, we would expect to see that the functional receptors could couple to Gpa1 and then trigger downstream FUS1-promoter-driven expression of GFP, together with cell cycle arrest at G1 phase (figure 6). The expression of GFP could be viewed by fluorescence microscopy; the cell cycle arrest could be confirmed by fluorescence-activated cell sorting (FACS). We expect to see the fusion receptor and RI7 respond to diacetyl and hexanal respectively, and have GFP expression and cell cycle arrest. In that case we could say that fusion receptor could functionally couple to Gpa1 and initiate downstream signalling.



Part 2
Second, we test whether our chimeric receptor could couple to Gαolf for optimized signal transduction, as well as construct a testable yeast system for odorant sensing.

Before testing, the yeast strain needs to be manipulated: we need to knock out the FAR1 gene, which encodes a protein that controls cell cycle arrest upon activation of the MAPK pathway. After deletion of the FAR1 gene, the yeast will still be viable after ligand binding. We also need to knock out the endogenous GPA1 gene, so that we could replace it with Gαolf. Due to the second messenger activity of the free G protein βγ subunit, haploid S. cerevisiae strains with a null mutation of GPA1 undergo constitutive pheromone response of G1 arrest, resulting in non-viability[9]. So, we need to first knock out the cell cycle regulatory gene FAR1 and afterwards, GPA1. To knock out these two genes, we have adopted the PCR-based tagging of yeast genes method, introduced by Janke C., et al, 2004[10].

To test for successful deletion, we will use both PCR confirmation (Figure 7) and phenotype observation after adding α-factor (no mating phenotype).





Next, we need to transform Gαolf into the double knock-out strain to check for positive transformants. It has been reported that Gαolf can not only complement for a GPA1 deficiency but also functionally couple to the pheromone receptor STE211. Thus we have developed assays to select for functional Gαolf transformants (Figure 8).





After confirmation of functional Gαolf, we would use this strain to test its ligand binding using the same method shown in Figure 6. However, this time we would expect to see no cell cycle arrest in any case since FAR1 has been deleted. We expect the ligand binding assay this time to give an optimized coupling and signal transduction.



Further Characterization of the Chimeric Protein Function

To further characterize how this chimeric receptor functions, we can do the following assays:

First, we can test how the recptor responds to different ligand concentrations. According to literature, C. elegans ODR-10 gives strongest response to 100μM diacetyl[11], and we can then compare the intensity of GFP production under a series of diacetyl concentrations.

Second, we can test the ligand specificity of the chimeric protein. According to literature, ODR-10 responds to the volatile molecule diacetyl, as well as the non-volatile molecules pyruvic acid and citric acid[13]. We can also test whether it can respond to other volatile molecules by setting up similar assays as shown in Figure 6.



  • Background
  • Experimental Design
  • Parts Design
  • Experimental Results
  • Future Work
  • References
  • HKUST